The epitopes recognized by Tra-1-81 and Tra-1-60 depend on glycosylation, meaning that carbohydrate modifications of podocalyxin influence antibody binding. This dependence helps these antibodies detect characteristic molecular forms associated with undifferentiated cells rather than recognizing podocalyxin without regard to its modification state. Consequently, staining patterns can change as cells progress toward differentiation.
Tra-1-81 and Tra-1-60 bind distinct epitopes associated with podocalyxin. Using both therefore provides complementary recognition patterns instead of relying on a single antibody interaction. Agreement or differences between their signals can strengthen cell characterization and quality-control assessments, particularly when researchers need to distinguish an undifferentiated population from cells that have begun producing more specialized progeny.
The characteristic podocalyxin forms recognized by these antibodies are abundant in embryonal carcinoma cells and human embryonic stem cells but typically decline as differentiation proceeds. A reduction in antibody signal can therefore indicate movement away from an undifferentiated state. Researchers can use this changing pattern to follow developmental progression and identify populations containing differentiated progeny.
Their usefulness comes from the association between antibody-reactive podocalyxin forms and undifferentiated human pluripotent stem cells. Detecting these forms gives researchers a practical molecular readout for evaluating whether a culture retains an undifferentiated population. This supports routine characterization and quality control, while changes in signal provide information about culture state during experimental manipulation.
In immunostaining, researchers use the antibodies to visualize cells carrying the relevant podocalyxin-associated epitopes. The resulting staining pattern shows where antibody-reactive undifferentiated cells are located within the sample and whether the population appears uniform or mixed. Comparing signals from Tra-1-81 and Tra-1-60 can add complementary evidence during cell characterization.
Flow cytometry measures antibody-associated signals across individual cells, allowing researchers to assess the proportion of a sample displaying Tra-1-81- or Tra-1-60-reactive epitopes. This supports population-level characterization rather than relying only on visual inspection. The measurements can help evaluate undifferentiated cell content and detect changes associated with reprogramming or differentiation.
During reprogramming, researchers can examine whether cells acquire the podocalyxin-associated forms detected by Tra-1-81 and Tra-1-60. Increasing detection of the corresponding epitopes supports characterization of cells that have gained features associated with an undifferentiated pluripotent state. Using the antibodies alongside cell-based measurements helps evaluate reprogramming outcomes and culture quality.
Researchers can measure Tra-1-81 and Tra-1-60 signals before and after differentiation to follow changes in the undifferentiated cell population. A typical decline in the recognized podocalyxin forms provides an indicator of progression toward specialized progeny. Applying both antibodies during characterization helps identify shifts in culture composition and supports quality-control decisions.